By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Syros Pharmaceuticals 

480 Arsenal Street
Suite 130
Watertown  Massachusetts  02472  U.S.A,
Phone: 617-744-1340 Fax: n/a


We are a therapeutics company passionately committed to applying our scientific leadership in the emerging field of gene control to transform the lives of patients with cancer and other diseases.

Founded by world-leading experts in gene regulation, and led by a seasoned management team, Syros is focused on developing new medicines that control genes that cause disease. Central to our approach is a proprietary drug development platform of integrated gene control assay technologies, computational biology, chemistry, and deep biologic insights that gives us an unprecedented understanding of and control over gene regulation. Our pioneering research and drug development capabilities provide us with the distinctive ability to identify new, important disease and patient-targeted gene control medicines.

Key Statistics

Ownership: Private

Web Site: Syros Pharmaceuticals


Company News
Syros Pharmaceuticals Announces New Research Published On Role Of Cell Signaling Pathways In Gene Control 3/20/2015 9:52:38 AM
Syros Pharmaceuticals To Present At Leading Investor Conferences 2/25/2015 11:01:00 AM
Syros Pharmaceuticals Presents New Data On Use Of Its Gene Control Platform For Predicting Drug Response 2/10/2015 1:43:32 PM
Syros Pharmaceuticals To Present At The 2015 Leerink Global Healthcare Conference 2/9/2015 10:57:39 AM
Syros Pharmaceuticals To Present At The 33rd Annual J.P. Morgan 2015 Healthcare Conference 1/7/2015 9:56:09 AM
Syros Pharmaceuticals Announces New Research Published On CDK7 In Lung And Pediatric Cancers 12/11/2014 8:09:17 AM
MA Startup Syros Pharmaceuticals Banks $53 Million Series B 10/27/2014 6:18:26 AM
Top 30 Life Science Startups To Watch In The U.S. 10/23/2014 4:27:21 AM
Syros Pharmaceuticals Presents Research On Gene Control In Acute Myeloid Leukemia At AACR Hematologic Malignancies Meeting 9/23/2014 9:51:34 AM
Syros Pharmaceuticals Appoints Genomics Entrepreneur Jorge Conde To Dual Role As Chief Financial Officer And Chief Product Officer 6/10/2014 6:54:59 AM